<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Glanzmann | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Glanzmann Thrombasthenia (GT)  Definition: A rare, inherited bleeding disorder characterized by: Normal platelet count Defective platelet aggregation Absent or severely reduced...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Glanzmann | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Glanzmann Thrombasthenia (GT)  Definition: A rare, inherited bleeding disorder characterized by: Normal platelet count Defective platelet aggregation Absent or severely reduced...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Glanzmann | Hematology">
<meta name="twitter:description" content="Overview of Glanzmann Thrombasthenia (GT)  Definition: A rare, inherited bleeding disorder characterized by: Normal platelet count Defective platelet aggregation Absent or severely reduced...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="active" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Microbiology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="glanzmann" class="section level1 unnumbered">
<h1>Glanzmann<a class="anchor" aria-label="anchor" href="#glanzmann"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-glanzmann-thrombasthenia-gt" class="section level2 unnumbered">
<h2>
<strong>Overview of Glanzmann Thrombasthenia (GT)</strong><a class="anchor" aria-label="anchor" href="#overview-of-glanzmann-thrombasthenia-gt"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A rare, inherited bleeding disorder characterized by:
<ul>
<li>Normal platelet count</li>
<li>Defective platelet aggregation</li>
<li>Absent or severely reduced expression of the platelet glycoprotein IIb/IIIa (GPIIb/IIIa) complex (also known as αIIbβ3 integrin)</li>
</ul>
</li>
<li>
<strong>Genetic Basis:</strong> Autosomal recessive inheritance of mutations in the genes encoding GPIIb (ITGA2B) or GPIIIa (ITGB3)</li>
<li>
<strong>Key Feature:</strong> Impaired platelet aggregation due to a defect in the fibrinogen receptor (GPIIb/IIIa), which is essential for platelet cross-linking and thrombus formation</li>
<li>
<strong>Clinical Significance:</strong> Leads to mucocutaneous bleeding tendencies, such as easy bruising, nosebleeds, gum bleeding, and prolonged bleeding after trauma or surgery</li>
</ul>
</div>
<div id="platelet-glycoprotein-iibiiia-gpiibiiia-complex" class="section level2 unnumbered">
<h2>
<strong>Platelet Glycoprotein IIb/IIIa (GPIIb/IIIa) Complex</strong><a class="anchor" aria-label="anchor" href="#platelet-glycoprotein-iibiiia-gpiibiiia-complex"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Structure:</strong> A heterodimeric complex consisting of two transmembrane glycoproteins:
<ul>
<li>GPIIb (αIIb or CD41)</li>
<li>GPIIIa (β3 or CD61)</li>
</ul>
</li>
<li>
<strong>Function:</strong>
<ul>
<li>Major Integrin on Platelets: GPIIb/IIIa is the most abundant integrin on the platelet surface</li>
<li>Fibrinogen Receptor: It acts as a receptor for fibrinogen, von Willebrand factor (vWF), fibronectin, and other adhesive ligands</li>
<li>Platelet Aggregation: GPIIb/IIIa mediates platelet aggregation by binding to fibrinogen, which forms bridges between adjacent platelets, leading to thrombus formation</li>
<li>Inside-Out Signaling: Platelet activation triggers a conformational change in GPIIb/IIIa that increases its affinity for fibrinogen</li>
<li>Outside-In Signaling: Binding of fibrinogen to GPIIb/IIIa triggers intracellular signaling pathways that stabilize platelet aggregates and promote clot retraction</li>
</ul>
</li>
</ul>
</div>
<div id="pathophysiology-of-glanzmann-thrombasthenia" class="section level2 unnumbered">
<h2>
<strong>Pathophysiology of Glanzmann Thrombasthenia</strong><a class="anchor" aria-label="anchor" href="#pathophysiology-of-glanzmann-thrombasthenia"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Genetic Mutations:</strong> Mutations in the genes encoding GPIIb (<em>ITGA2B</em>) or GPIIIa (<em>ITGB3</em>) lead to:
<ul>
<li>Decreased Expression of GPIIb/IIIa on the Platelet Surface:
<ul>
<li>Type I GT: Severely reduced or absent GPIIb/IIIa expression (&lt;5% of normal)</li>
<li>Type II GT: Reduced GPIIb/IIIa expression (5-20% of normal)</li>
</ul>
</li>
<li>Dysfunctional GPIIb/IIIa Complex:
<ul>
<li>Abnormal structure of the GPIIb/IIIa complex, impairing its ability to bind to fibrinogen and other ligands</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Impaired Platelet Aggregation:</strong>
<ul>
<li>Deficiency or dysfunction of GPIIb/IIIa impairs platelet aggregation, preventing platelets from forming stable clots</li>
<li>Leads to a prolonged bleeding time and increased susceptibility to bleeding</li>
</ul>
</li>
</ul>
</div>
<div id="clinical-features-3" class="section level2 unnumbered">
<h2>
<strong>Clinical Features</strong><a class="anchor" aria-label="anchor" href="#clinical-features-3"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Mucocutaneous Bleeding:</strong> The hallmark of GT
<ul>
<li>Easy bruising (purpura)</li>
<li>Nosebleeds (epistaxis)</li>
<li>Gum bleeding (gingival bleeding)</li>
<li>Menorrhagia (heavy menstrual bleeding) in women</li>
<li>Prolonged bleeding after minor cuts or dental procedures</li>
</ul>
</li>
<li>
<strong>Severity:</strong>
<ul>
<li>Severity of bleeding varies among patients, even within the same type of GT</li>
<li>Bleeding episodes can be spontaneous or triggered by trauma or surgery</li>
</ul>
</li>
<li>
<strong>Joint Bleeds (Hemarthrosis):</strong> Rare in GT, unlike hemophilia</li>
</ul>
</div>
<div id="laboratory-findings-10" class="section level2 unnumbered">
<h2>
<strong>Laboratory Findings</strong><a class="anchor" aria-label="anchor" href="#laboratory-findings-10"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Complete Blood Count (CBC):</strong>
<ul>
<li>Platelet count: Usually normal</li>
<li>RBC and WBC counts: Normal</li>
</ul>
</li>
<li>
<strong>Peripheral Blood Smear:</strong>
<ul>
<li>Normal platelet morphology and number (except for possible macroplatelets)</li>
<li>No platelet clumps</li>
</ul>
</li>
<li>
<strong>Bleeding Time:</strong>
<ul>
<li>Prolonged (often significantly prolonged)</li>
<li>
<em>Note:</em> The bleeding time is not a very specific or sensitive test and is rarely used now. PFA testing has taken its place.</li>
</ul>
</li>
<li>
<strong>Platelet Function Analyzer (PFA-100):</strong>
<ul>
<li>Prolonged Closure Time with Both Epinephrine and ADP Cartridges
<ul>
<li>Suggests a global platelet dysfunction</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Platelet Aggregation Studies:</strong> The key diagnostic test for GT
<ul>
<li>Absent or Severely Reduced Aggregation with ADP, Collagen, Epinephrine, and Thrombin
<ul>
<li>These agonists require functional GPIIb/IIIa to induce platelet aggregation</li>
</ul>
</li>
<li>Normal Aggregation with Ristocetin
<ul>
<li>Ristocetin induces platelet aggregation by binding vWF to GPIb/IX/V (which is normal in GT)</li>
<li>Since the GPIIb/IIIa complex is not required for this interaction, ristocetin-induced aggregation is normal in GT</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Clot Retraction:</strong>
<ul>
<li>Absent or Impaired</li>
<li>GPIIb/IIIa is required for clot retraction, so this process is abnormal in GT</li>
</ul>
</li>
<li>
<strong>Flow Cytometry Immunophenotyping:</strong>
<ul>
<li>Decreased or Absent Expression of GPIIb (CD41) and/or GPIIIa (CD61) on Platelets
<ul>
<li>Confirms the defect in the GPIIb/IIIa complex</li>
<li>Can differentiate between Type I (severely reduced expression) and Type II (reduced expression) GT</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="diagnostic-approach-1" class="section level2 unnumbered">
<h2>
<strong>Diagnostic Approach</strong><a class="anchor" aria-label="anchor" href="#diagnostic-approach-1"><i class="fas fa-link"></i></a>
</h2>
<ol style="list-style-type: decimal">
<li>
<strong>Suspect GT:</strong> In a patient with:
<ul>
<li>Lifelong history of mucocutaneous bleeding</li>
<li>Normal platelet count</li>
<li>Prolonged bleeding time (or abnormal PFA result)</li>
</ul>
</li>
<li>
<strong>Perform Platelet Aggregation Studies:</strong> Absent aggregation with ADP, collagen, epinephrine, and thrombin, but normal aggregation with ristocetin, is highly suggestive of GT</li>
<li>
<strong>Confirm Diagnosis with Flow Cytometry:</strong> Demonstrate decreased or absent expression of GPIIb (CD41) and/or GPIIIa (CD61) on platelets</li>
<li>
<strong>Rule Out Other Platelet Function Disorders:</strong>
<ul>
<li>Acquired platelet dysfunction (e.g., drug-induced): Recent exposure to aspirin or other antiplatelet medications</li>
<li>Bernard-Soulier Syndrome: Giant platelets, absent ristocetin-induced aggregation that is <em>not</em> corrected by normal plasma, abnormal GPIb/IX/V expression</li>
</ul>
</li>
</ol>
</div>
<div id="treatment-and-management-6" class="section level2 unnumbered">
<h2>
<strong>Treatment and Management</strong><a class="anchor" aria-label="anchor" href="#treatment-and-management-6"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li><p><strong>No Specific Cure:</strong> Treatment is primarily supportive and aimed at controlling bleeding episodes</p></li>
<li><p><strong>Avoid Platelet Inhibitors:</strong> Aspirin and other antiplatelet medications are contraindicated</p></li>
<li>
<p><strong>Local Hemostatic Measures:</strong></p>
<ul>
<li>Topical thrombin or fibrin sealants to control minor bleeding</li>
<li>Pressure dressings to control bleeding from cuts or wounds</li>
</ul>
</li>
<li>
<p><strong>Antifibrinolytic Agents:</strong></p>
<ul>
<li>Tranexamic acid or aminocaproic acid may be used to control mucosal bleeding (e.g., nosebleeds, menorrhagia)</li>
<li>These medications inhibit fibrinolysis (the breakdown of blood clots)</li>
</ul>
</li>
<li>
<p><strong>Recombinant Factor VIIa (rFVIIa):</strong></p>
<ul>
<li>May be used to control bleeding in patients with GT</li>
<li>Mechanism of action is not fully understood, but it may promote thrombin generation and platelet activation</li>
</ul>
</li>
<li>
<p><strong>Platelet Transfusions:</strong></p>
<ul>
<li>Used to treat severe bleeding episodes or before surgery</li>
<li>Patients may develop alloantibodies (antibodies against foreign platelets) with repeated transfusions, making subsequent transfusions less effective</li>
<li>HLA-matched platelets may be required in patients who have become alloimmunized</li>
</ul>
</li>
<li>
<p><strong>Hematopoietic Stem Cell Transplantation (HSCT):</strong></p>
<ul>
<li>Potentially curative option for severe cases of GT</li>
<li>Involves replacing the patient’s damaged bone marrow with healthy stem cells from a donor</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-46" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-46"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Glanzmann Thrombasthenia (GT):</strong> Rare inherited bleeding disorder characterized by defective platelet aggregation</li>
<li>
<strong>GPIIb/IIIa (αIIbβ3 Integrin):</strong> Platelet glycoprotein complex that binds to fibrinogen and mediates platelet aggregation</li>
<li>
<strong>Platelet Aggregation Studies:</strong> Tests that measure the ability of platelets to clump together</li>
<li>
<strong>Ristocetin:</strong> An antibiotic that induces vWF-dependent platelet agglutination</li>
<li>
<strong>Alloantibodies:</strong> Antibodies against foreign antigens (e.g., transfused platelets)</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="bernard-soulier.html">Bernard-Soulier</a></div>
<div class="next"><a href="cell-counts.html">Cell Counts</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#glanzmann">Glanzmann</a></li>
<li><a class="nav-link" href="#overview-of-glanzmann-thrombasthenia-gt">Overview of Glanzmann Thrombasthenia (GT)</a></li>
<li><a class="nav-link" href="#platelet-glycoprotein-iibiiia-gpiibiiia-complex">Platelet Glycoprotein IIb/IIIa (GPIIb/IIIa) Complex</a></li>
<li><a class="nav-link" href="#pathophysiology-of-glanzmann-thrombasthenia">Pathophysiology of Glanzmann Thrombasthenia</a></li>
<li><a class="nav-link" href="#clinical-features-3">Clinical Features</a></li>
<li><a class="nav-link" href="#laboratory-findings-10">Laboratory Findings</a></li>
<li><a class="nav-link" href="#diagnostic-approach-1">Diagnostic Approach</a></li>
<li><a class="nav-link" href="#treatment-and-management-6">Treatment and Management</a></li>
<li><a class="nav-link" href="#key-terms-46">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Microbiology/blob/blob/main/Rmd/03-13-platelet-qualitative-gt.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Microbiology/blob/edit/main/Rmd/03-13-platelet-qualitative-gt.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-03-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
